AR128353A1 - Síntesis de un inhibidor de kif18a - Google Patents
Síntesis de un inhibidor de kif18aInfo
- Publication number
- AR128353A1 AR128353A1 ARP230100178A ARP230100178A AR128353A1 AR 128353 A1 AR128353 A1 AR 128353A1 AR P230100178 A ARP230100178 A AR P230100178A AR P230100178 A ARP230100178 A AR P230100178A AR 128353 A1 AR128353 A1 AR 128353A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- kif18a
- inhibitor
- synthesis
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C313/02—Sulfinic acids; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263303470P | 2022-01-26 | 2022-01-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR128353A1 true AR128353A1 (es) | 2024-04-24 |
Family
ID=85328813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP230100178A AR128353A1 (es) | 2022-01-26 | 2023-01-26 | Síntesis de un inhibidor de kif18a |
Country Status (12)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL283639B2 (en) | 2018-12-20 | 2024-06-01 | Amgen Inc | Kif18a inhibitors |
| CR20250087A (es) | 2022-08-18 | 2025-07-11 | Accent Therapeutics Inc | Inhibidores de kif18a y usos de estos |
| CN115925589A (zh) * | 2022-12-26 | 2023-04-07 | 诚达药业股份有限公司 | 一种脂肪族亚磺酸钙盐及其制备方法 |
| CN121693499A (zh) * | 2023-08-16 | 2026-03-17 | 上海湃隆生物科技有限公司 | 驱动蛋白kif18a抑制剂及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL283639B2 (en) * | 2018-12-20 | 2024-06-01 | Amgen Inc | Kif18a inhibitors |
| JP2023521802A (ja) * | 2020-04-14 | 2023-05-25 | アムジエン・インコーポレーテツド | 新生物疾患の処置のためのkif18a阻害剤 |
-
2023
- 2023-01-26 AU AU2023211589A patent/AU2023211589A1/en active Pending
- 2023-01-26 MX MX2024009163A patent/MX2024009163A/es unknown
- 2023-01-26 CA CA3248925A patent/CA3248925A1/en active Pending
- 2023-01-26 AR ARP230100178A patent/AR128353A1/es unknown
- 2023-01-26 CN CN202380018655.9A patent/CN118922406A/zh active Pending
- 2023-01-26 IL IL314221A patent/IL314221A/en unknown
- 2023-01-26 WO PCT/US2023/011636 patent/WO2023146973A1/en not_active Ceased
- 2023-01-26 US US18/832,887 patent/US20250129050A1/en active Pending
- 2023-01-26 EP EP23706921.6A patent/EP4469437A1/en active Pending
- 2023-01-26 KR KR1020247024721A patent/KR20240144140A/ko active Pending
- 2023-01-26 JP JP2024543870A patent/JP2025505892A/ja active Pending
- 2023-01-30 TW TW112103047A patent/TW202342451A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3248925A1 (en) | 2023-08-03 |
| WO2023146973A1 (en) | 2023-08-03 |
| AU2023211589A1 (en) | 2024-07-25 |
| US20250129050A1 (en) | 2025-04-24 |
| KR20240144140A (ko) | 2024-10-02 |
| TW202342451A (zh) | 2023-11-01 |
| IL314221A (en) | 2024-09-01 |
| EP4469437A1 (en) | 2024-12-04 |
| JP2025505892A (ja) | 2025-03-03 |
| MX2024009163A (es) | 2024-08-09 |
| CN118922406A (zh) | 2024-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024009163A (es) | Sintesis de un inhibidor de kif18a. | |
| CO2022012476A2 (es) | Hidrato cristalino de un compuesto inhibidor de jak | |
| PE20231938A1 (es) | Inhibidores de cdk y metodos de uso de estos | |
| CL2022001091A1 (es) | Dihidrobenzofurano e inden analogos como inhibidores de sarcómero cardíaco (divisional de solicitud 202001871). | |
| AR111960A1 (es) | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación | |
| CY1111481T1 (el) | Υποκατεστημενα αρυλοκυκλοπροπυλακεταμιδια ως ενεργοποιητες γλυκοκινασης | |
| ES2052452B1 (es) | Procedimiento de preparacion de inhibidores duales de no-sintasa y ciclooxigenasa. | |
| CL2021000481A1 (es) | Inhibidores de sarcómeros cardíacos. | |
| DK1485359T3 (da) | Natriumkanalblokkere | |
| PE20050012A1 (es) | Compuestos de benzopirano como inhibidores de la ciclooxigenasa-2 | |
| AR124694A1 (es) | Hidrato cristalino de sal de sodio de topramezona novedoso y método de preparación del mismo | |
| ECSP066968A (es) | Compuestos de metil-aril o heteroaril-amida sustituida | |
| CY1105899T1 (el) | Πυριδινοϋλοπιπepιδινες ως 5-ht1f αγωνιστες | |
| PE20242071A1 (es) | Compuestos moduladores de diacilglicerol quinasa | |
| TW200635585A (en) | Monocyclic substituted methanones | |
| CO2024013702A2 (es) | Derivados de pirido-[3,4-d]piridazina amina útiles como derivados de nlrp3 | |
| CL2023001301A1 (es) | 1,4-diazepanonas bicíclicas y sus usos terapéuticos. | |
| AR129946A1 (es) | Inhibidores de cbl-b y métodos de uso de los mismos | |
| UY39898A (es) | Un proceso para la preparación de piroxasulfona. | |
| AR041861A1 (es) | Feniliso (tio) cianatos, procesos e intermediarios para su preparacion. | |
| ES2421447T3 (es) | Métodos para proteger frente a apoptosis usando lipopéptidos | |
| CO2023006912A2 (es) | Nuevos derivados de indazol acetileno | |
| CO2022012773A2 (es) | Moduladores de nampt | |
| DE60229054D1 (de) | Synthese von zyklopentadien derivaten | |
| CR20240173A (es) | Compuestos de cd73 |